abstract |
The present invention relates to novel compounds useful as kinase inhibitors. The compounds of the present invention are tyrosine kinase inhibitors. In particular, the compounds of the present invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The present invention also contemplates the use of these compounds in the treatment of conditions treatable by inhibition of Bruton's tyrosine kinase, such as cancer, lymphoma, leukemia and immune diseases. |